Kodiak Sciences shares surge after eye drug succeeds in late-stage study | Reuters Skip to main content Exclusive news, data and analytics for financial market professionalsLearn more aboutRefinitiv Companies Kodiak Sciences Inc Follow Kodiak said the results support an application for approval with the U.S. Food and Drug Administration, and that it plans to accelerate the submission. Reporting by Siddhi Mahatole in Bengaluru; Editing by Leroy Leo Our Standards: The Thomson Reuters Trust Principles., opens ...